ArticleSurgical case reports2026
Rapid Development of Diffuse-Type Remnant Pancreatic Cancer Following Obstructive Pancreatitis after Pancreaticoduodenectomy for Distal Bile Duct Carcinoma: A Case Report.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDistal bile duct carcinoma (DBDC) and pancreatic ductal adenocarcinoma (PDAC) are aggressive malignancies; however, their metachronous occurrence within a short postoperative timeframe is extremely rare. We present an extremely rare case of diffuse-type PDAC that rapidly developed only 16 months after curative resection of DBDC. CASE PRESENTATION: A 60-year-old woman presented with obstructive jaundice. Contrast-enhanced CT revealed circumferential wall thickening with enhancement in the intrapancreatic bile duct. Endoscopic ultrasound-guided tissue acquisition confirmed adenocarcinoma, resulting in a diagnosis of resectable DBDC. She underwent laparoscopy-assisted subtotal stomach-preserving pancreaticoduodenectomy, and the pathology demonstrated Stage IIB (pT2N1M0; UICC/AJCC 8th edition). The resection margin was negative (R0). Adjuvant chemotherapy with gemcitabine, cisplatin, and S-1 was administered for 3 months. Follow-up imaging at 16 months postoperatively revealed newly-developed and progressive main pancreatic duct (MPD) dilatation, diffuse enlargement of the remnant pancreas, and a poorly enhancing mass in the pancreatic tail. The patient also experienced epigastric and back pain, raising suspicion of obstructive pancreatitis. Endoscopic ultrasound-guided sampling again demonstrated adenocarcinoma, leading to a clinical diagnosis of
conclusionsThis case highlights a rare, rapidly occurring metachronous combination of DBDC and highly aggressive diffuse-type pancreatic cancer. To our knowledge, this is the first case report of surgically treated remnant pancreatic cancer after DBDC with comprehensive genetic profiling. Obstructive pancreatitis secondary to pancreaticojejunostomy stricture was the most plausible underlying carcinogenic factor. Vigilant surveillance of postoperative morphological changes, particularly progressive MPD dilatation, is required to prevent delayed recognition of fatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.